文献速递腹部技术与安全MR

肝血管肉瘤与上皮样血管内皮瘤的临床及MRI特征比较

Comparison of clinical and MRI features of hepatic angiosarcoma and epithelioid hemangioendothelioma.
PubMed 文献 · Abdom Radiol (NY) · 2024-08-13

回顾性纳入2008至2023年经病理确诊并接受钆塞酸二钠增强MRI的32例肝血管肉瘤(AS)与38例肝上皮样血管内皮瘤(EHE)患者,比较临床及影像特征。AS患者年龄更大、实验室异常更常见、总生存期更差,MRI多表现为大主灶伴小结节、边缘不清及离心性强化;EHE则以靶环样表现为特征。

要点

  • AS多见于≥60岁患者(81.3%),常伴实验室异常,总生存期较EHE差(11.2 vs 31.8个月)。
  • AS的MRI特征为大主灶伴小结节(43.8%)、边缘不清(46.9%)及离心性强化。
  • EHE特征性表现为靶环样(T2WI 78.9%、DWI 54.1%、多期增强65.8%),强化程度多低于主动脉。

核心结论

  • 年龄≥60岁、伴实验室异常、MRI示大主灶伴小结节、奇异强化及离心性强化、尤其见于肝硬化背景的肝脏,提示AS可能性大于EHE(原文结论,作者认为)。

研究设计与样本

  • 回顾性研究,纳入2008至2023年经病理确诊的AS 32例(女18例[56.3%],中位年龄68岁)和EHE 38例(女24例[63.2%],中位年龄51岁),均行钆塞酸二钠增强MRI;两名放射科医师独立阅片,采用Wilcoxon秩和检验和Fisher精确检验比较特征,以3年限制性平均生存时间比较总生存。

关键影像表现/征象

  • AS常表现为一个大主灶伴较小结节(14/32,43.8%),边缘多不清(15/32,46.9%)。
  • EHE多表现为大小相近的结节(24/38,63.2%;P=0.015),边缘清楚(30/38,78.9%;P=0.002)。
  • AS常见奇异形态病灶明显强化,呈离心性强化模式。
  • EHE特征性表现为靶环样(T2WI 78.9%、DWI 54.1%、多期增强65.8%;P≤0.002),强化程度多低于主动脉。
  • AS肝硬化表现更常见(62.5%,P<0.001),伴肝胆期肝实质强化减低(31.3%,P<0.001)及腹水(37.5%,P=0.010)。

诊断标准与关键数值

  • AS:年龄多≥60岁(81.3%,P<0.001),实验室异常更常见(P≤0.018),总生存期11.2个月 vs EHE 31.8个月(P<0.001)。
  • EHE靶环样表现:T2WI 78.9%、DWI 54.1%、多期增强65.8%(P≤0.002)。
  • 肝胆期AS均呈低信号,EHE 39.5%呈靶环样(P<0.001)。

临床应用与阅片要点

  • 老年患者伴实验室异常、肝硬化背景及大主灶伴小结节、离心性强化时,应提示AS可能(作者认为)。
  • EHE的靶环样表现(T2WI、DWI及多期增强)有助于与AS鉴别。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Differentiating hepatic epithelioid hemangioendothelioma (EHE) and angiosarcoma (AS), the two most common vascular tumors in the liver, is important due to disparities in their prognosis and treatment. We aimed to compare clinical and MRI features of the two tumors.

METHODS: This retrospective study included patients with pathologically-confirmed AS or EHE who underwent MRI using gadoxetate disodium between 2008 and 2023. Two radiologists independently reviewed MR images. Wilcoxon rank sum and Fisher's exact tests were used to compare clinical and imaging features. Overall survival was compared using restricted mean survival time at 3 years.

RESULTS: 32 patients with AS (18 women [56.3%]; median age, 68 years) and 38 with EHE (24 women [63.2%]; 51 years) were included. Patients with AS were generally older (81.3% ≥ 60 years; P < 0.001), had more frequent laboratory abnormalities (P ≤ 0.018), and poorer overall survival (11.2 vs. 31.8 months; P < 0.001) than those with EHE. On MRI, a large dominant mass accompanied by smaller nodules (14/32, 43.8%), often with ill-defined margins (15/32, 46.9%) was prevalent in AS; compared with nodules of similar sizes (24/38, 63.2%; P = 0.015) with well-defined margin (30/38, 78.9%; P = 0.002) in EHE. Cirrhotic appearance of the liver was more frequent in AS (62.5%, P < 0.001), along with decreased parenchymal enhancement on hepatobiliary phase (31.3%, P < 0.001) and ascites (37.5%, P = 0.010). AS frequently presented with avid enhancement of bizarrely-shaped foci, with a centrifugal enhancement pattern. In comparison, targetoid appearance was characteristic of EHE (78.9% on T2-weighted, 54.1% on diffusion-weighted, 65.8% on multiphase images) (P ≤ 0.002), with enhancement degree typically lower than that of the aorta. On hepatobiliary phase, all the AS exhibited hypointensity, while 39.5% of EHE showed targetoid appearance (P < 0.001).

CONCLUSION: Patients aged ≥ 60 years presenting with laboratory abnormalities, typically with a large dominant mass accompanied by smaller nodules, exhibiting avid, bizarre, and centrifugal enhancement-particularly in the cirrhotic-appearing liver-suggests the likelihood of AS over EHE.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Kim HY, Hong S, Heo S, et al. Comparison of clinical and MRI features of hepatic angiosarcoma and epithelioid hemangioendothelioma. Abdom Radiol (NY). 2024. PMID: 39136718. doi:10.1007/s00261-024-04513-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。